Activation of AMPK-PGC-1α pathway ameliorates peritoneal dialysis related peritoneal fibrosis in mice by enhancing mitochondrial biogenesis

References

• Li PK, Chow KM, Van de Luijtgaarden MW, et al. Changes in the worldwide epidemiology of peritoneal dialysis. Nat Rev Nephrol. 2017;13(2):90–103.
   PubMed Web of Science ®Google Scholar
• Davies SJ. Peritoneal dialysis-current status and future challenges. Nat Rev Nephrol. 2013;9(7):399–408.
   PubMed Web of Science ®Google Scholar
• Devuyst O, Margetts PJ, Topley N. The pathophysiology of the peritoneal membrane. J Am Soc Nephrol. 2010;21(7):1077–1085.
   PubMed Web of Science ®Google Scholar
• Zhou Q, Bajo MA, Del Peso G, et al. Preventing peritoneal membrane fibrosis in peritoneal dialysis patients. Kidney Int. 2016;90(3):515–524.
   PubMed Web of Science ®Google Scholar
• Krediet RT, Struijk DG. Peritoneal changes in patients on long-term peritoneal dialysis. Nat Rev Nephrol. 2013;9(7):419–429.
   PubMed Web of Science ®Google Scholar
• Aroeira LS, Aguilera A, Sánchez-Tomero JA, et al. Epithelial to mesenchymal transition and peritoneal membrane failure in peritoneal dialysis patients: pathologic significance and potential therapeutic interventions. J Am Soc Nephrol. 2007;18(7):2004–2013.
   PubMed Web of Science ®Google Scholar
• Schilte MN, Celie JWAM, Wee PMt, et al. Factors contributing to peritoneal tissue remodeling in peritoneal dialysis. Perit Dial Int. 2009;29(6):605–617.
   PubMed Web of Science ®Google Scholar
• Bellón T, Martínez V, Lucendo B, et al. Alternative activation of macrophages in human peritoneum: implications for peritoneal fibrosis. Nephrol Dial Transplant. 2011;26(9):2995–3005.
   PubMed Web of Science ®Google Scholar
• Ylikallio E, Suomalainen A. Mechanisms of mitochondrial diseases. Ann Med. 2012;44(1):41–59.
   PubMed Web of Science ®Google Scholar
• Rahman J, Rahman S. Mitochondrial medicine in the omics era. Lancet. 2018;391(10139):2560–2574.
   PubMed Web of Science ®Google Scholar
• Uittenbogaard M, Chiaramello A. Mitochondrial biogenesis: a therapeutic target for neurodevelopmental disorders and neurodegenerative diseases. Curr Pharm Des. 2014;20(35):5574–5593.
   PubMed Web of Science ®Google Scholar
• Kelly DP, Scarpulla RC. Transcriptional regulatory circuits controlling mitochondrial biogenesis and function. Genes Dev. 2004;18(4):357–368.
   PubMed Web of Science ®Google Scholar
• Gibb AA, Lazaropoulos MP, Elrod JW. Myofibroblasts and fibrosis: mitochondrial and metabolic control of cellular differentiation. Circ Res. 2020;127(3):427–447.
   PubMed Web of Science ®Google Scholar
• Li S, Zhang H, Chang J, et al. Iron overload and mitochondrial dysfunction orchestrate pulmonary fibrosis. Eur J Pharmacol. 2021;912:174613.
   PubMed Web of Science ®Google Scholar
• Jiang M, Bai M, Lei J, et al. Mitochondrial dysfunction and the AKI-to-CKD transition. Am J Physiol Renal Physiol. 2020;319(6):F1105–F1116.
   PubMed Web of Science ®Google Scholar
• McCommis KS, Finck BN. Treating hepatic steatosis and fibrosis by modulating mitochondrial pyruvate metabolism. Cell Mol Gastroenterol Hepatol. 2019;7(2):275–284.
   PubMed Web of Science ®Google Scholar
• Inoue H, Torigoe K, Torigoe M, et al. Mitochonic acid-5 ameliorates chlorhexidine gluconate-induced peritoneal fibrosis in mice. Med Mol Morphol. 2022;55(1):27–40.
   PubMed Web of Science ®Google Scholar
• Li ZH, Xu R, Shi J, et al. Astragalus total saponins ameliorate peritoneal fibrosis by promoting mitochondrial synthesis and inhibiting apoptosis. Am J Chin Med. 2022;50(1):261–274.
   PubMedGoogle Scholar
• Loureiro J, Aguilera A, Selgas R, et al. Blocking TGF-β1 protects the peritoneal membrane from dialysate-induced damage. J Am Soc Nephrol. 2011;22(9):1682–1695.
   PubMed Web of Science ®Google Scholar
• Li X, Liu H, Sun L, et al. MicroRNA-302c modulates peritoneal dialysis-associated fibrosis by targeting connective tissue growth factor. J Cell Mol Med. 2019;23(4):2372–2383.
   PubMed Web of Science ®Google Scholar
• Wu J, Xing C, Zhang L, et al. Autophagy promotes fibrosis and apoptosis in the peritoneum during long-term peritoneal dialysis. J Cell Mol Med. 2018;22(2):1190–1201.
   PubMed Web of Science ®Google Scholar
• Wu J, Li X, Zhu G, et al. The role of resveratrol-induced mitophagy/autophagy in peritoneal mesothelial cells inflammatory injury via NLRP3 inflammasome activation triggered by mitochondrial ROS. Exp Cell Res. 2016;341(1):42–53.
   PubMed Web of Science ®Google Scholar
• Miao J, Liu J, Niu J, et al. Wnt/β-catenin/RAS signaling mediates age-related renal fibrosis and is associated with mitochondrial dysfunction. Aging Cell. 2019;18(5):e13004.
   PubMed Web of Science ®Google Scholar
• Krishnasamy Y, Gooz M, Li L, et al. Role of mitochondrial depolarization and disrupted mitochondrial homeostasis in non-alcoholic steatohepatitis and fibrosis in mice. Int J Physiol Pathophysiol Pharmacol. 2019;11(5):190–204.
   PubMedGoogle Scholar
• Shao Q, Meng L, Lee S, et al. Empagliflozin, a sodium glucose co-transporter-2 inhibitor, alleviates atrial remodeling and improves mitochondrial function in high-fat diet/streptozotocin-induced diabetic rats. Cardiovasc Diabetol. 2019;18(1):165.
   PubMed Web of Science ®Google Scholar
• Yu G, Tzouvelekis A, Wang R, et al. Thyroid hormone inhibits lung fibrosis in mice by improving epithelial mitochondrial function. Nat Med. 2018;24(1):39–49.
   PubMed Web of Science ®Google Scholar
• Zhang L, Zhang Y, Chang X, et al. Imbalance in mitochondrial dynamics induced by low PGC-1α expression contributes to hepatocyte EMT and liver fibrosis. Cell Death Dis. 2020;11(4):226.
   PubMed Web of Science ®Google Scholar
• Liao X, Lv X, Zhang Y, et al. Fluorofenidone inhibits UUO/IRI-Induced renal fibrosis by reducing mitochondrial damage. Oxid Med Cell Longev. 2022;2022:2453617.
   PubMed Web of Science ®Google Scholar
• Rangarajan S, Bone NB, Zmijewska AA, et al. Metformin reverses established lung fibrosis in a bleomycin model. Nat Med. 2018;24(8):1121–1127.
   PubMed Web of Science ®Google Scholar
• Jia D, Hou L, Lv Y, et al. Postinfarction exercise training alleviates cardiac dysfunction and adverse remodeling via mitochondrial biogenesis and SIRT1/PGC-1α/PI3K/akt signaling. J Cell Physiol. 2019;234(12):23705–23718.
   PubMed Web of Science ®Google Scholar
• Hardie DG, Ross FA, Hawley SA. AMPK: a nutrient and energy sensor that maintains energy homeostasis. Nat Rev Mol Cell Biol. 2012;13(4):251–262.
   PubMed Web of Science ®Google Scholar
• Inoki K, Kim J, Guan KL. AMPK and mTOR in cellular energy homeostasis and drug targets. Annu Rev Pharmacol Toxicol. 2012;52:381–400.
   PubMed Web of Science ®Google Scholar
• Hassan I, Didari F, Khan T, et al. A review on the protective effects of metformin in Sepsis-Induced organ failure. Cell. 2020;21(4):363–370.
   PubMed Web of Science ®Google Scholar